Spotlight Therapeutics Funding: $67M Raised, Series B (2022)
Spotlight Therapeutics is based in Hayward, California. It has raised $67M in total funding. Latest round: Series B. Backed by GV (Google Ventures).
Spotlight Therapeutics funding overview
Spotlight Therapeutics is based in Hayward, California. Spotlight Therapeutics has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2022. The round record for Spotlight Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include GV (Google Ventures).
Spotlight Therapeutics at a glance
Total raised
$67M
Latest round
Series B
Latest round date
March 2022
Headquarters
Hayward, California
Notable investors
GV (Google Ventures)
Frequently asked about Spotlight Therapeutics funding
How much has Spotlight Therapeutics raised?
Spotlight Therapeutics has raised $67M in total disclosed funding across the rounds on record.
Who has invested in Spotlight Therapeutics?
GV (Google Ventures) are named among the investors backing Spotlight Therapeutics.
What was the latest Spotlight Therapeutics funding round?
The most recent disclosed round is a Series B, announced in March 2022.
Where is Spotlight Therapeutics based?
Spotlight Therapeutics is based in Hayward, California.
When did Spotlight Therapeutics last raise?
The last disclosed Spotlight Therapeutics round closed in March 2022 at Series B.
Every Spotlight Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Hayward at a similar stage.
